Audio Podcast

Share

Program Content

Activities

  • CDK4/6i for HR+/HER2- MBC
    Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 19, 2021

    Expires: August 18, 2022

  • <i>PodcastPearls</i>: CDK4/6i Slideset
    PodcastPearls: Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
    Podcast Episodes
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 24, 2021

    Expires: August 23, 2022

Faculty

cover img faculity

Matthew P. Goetz, MD

Professor of Oncology and Pharmacology
Director, Mayo Breast Cancer SPORE
Co-PI, Womens Cancer Program
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Supporters

Lilly

Partners

Smart Patients

ProCE Banner